Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
1.41 USD +2.92% Intraday chart for Carisma Therapeutics, Inc. -4.73% -51.88%
05-16 Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, A Novel HER2-Targeting CAR-Monocyte CI
05-09 Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CARISMA THERAPEUTICS, INC. Stock Carisma Therapeutics, Inc.
 58.58M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 21.84B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. CARM Stock
  4. Charts Carisma Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW